$4.00 to $2.40 in a couple of months: shows how important this...

$4.00 to $2.40 in a couple of months: shows how important this can be.

Sydney - Tuesday - August 29: (RWE Aust Business News) -
Cellestis Ltd (ASX:CST) reported a net loss of $3.62 million for the year
to June 30 2006 on revenue of $6.12m.
This compares to a loss of $3.35m and revenue of $2.5m in the previous year.
The company said product sales in the USA increased in the last half of the year following the issue of CDC guidelines for the use of the QFT-Gold test.
Expansion of European marketing activities, along with the issue of regional guidelines in the UK and Switzerland, led to growing input from that region.
Subsequent to the reporting period, approval was obtained for sale of QFT-Gold In Tube in Canada.
Further national guidelines for QFT-Gold use are expected from Europe and other nations.